focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Apr 2017 17:57

RNS Number : 5120C
Circassia Pharmaceuticals Plc
13 April 2017
 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Circassia Pharmaceuticals Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

 X

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

 Woodford Investment Management Ltd ("Woodford")

4. Full name of shareholder(s)  (if different from 3.):iv

Clients of Woodford

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

 12/04/2017

6. Date on which issuer notified:

 13/04/2017

7. Threshold(s) that is/are crossed orreached: vi, vii

21%,20%,19%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

%of voting rightsx

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BJVD3B28

60,777,349

60,777,349

60,777,349

60,777,349

0

18.29%

0.00%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

60,777,349

18.29 %

 

 

 

 

 

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Julien Cotta

15. Contact telephone number:

01865 405560

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOVNRBVASAAR
Date   Source Headline
3rd Apr 201712:20 pmRNSResult of General Meeting on 3 April 2017
31st Mar 20177:00 amRNSTotal Voting Rights
29th Mar 20175:56 pmRNSHolding(s) in Company
17th Mar 20172:23 pmRNSPublication of a Prospectus
17th Mar 20177:00 amRNSCollaboration with AstraZeneca
28th Feb 20177:00 amRNSTotal Voting Rights Update
31st Jan 20177:00 amRNSTotal Voting Rights
9th Jan 20175:03 pmRNSBlock listing Interim Review
30th Dec 20167:00 amRNSTotal Voting Rights
16th Dec 20162:44 pmRNSDirectorate Change
30th Nov 20163:12 pmRNSTotal Voting Rights Update
8th Nov 20164:40 pmRNSSecond Price Monitoring Extn
8th Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20167:00 amRNSTotal Voting Rights
30th Sep 20167:00 amRNSTotal Voting Rights
27th Sep 20167:00 amRNSInterim Results
20th Sep 20169:59 amRNSHolding(s) in Company
2nd Sep 20164:35 pmRNSPrice Monitoring Extension
31st Aug 20169:00 amRNSTotal Voting Rights
1st Aug 20163:55 pmRNSHolding(s) in Company
29th Jul 20167:00 amRNSTotal Voting Rights
19th Jul 20164:40 pmRNSSecond Price Monitoring Extn
19th Jul 20164:35 pmRNSPrice Monitoring Extension
18th Jul 20165:58 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Jul 20165:54 pmRNSTotal Voting Rights
15th Jul 201611:00 amRNSNotice of Results
22nd Jun 20163:51 pmRNSHolding(s) in Company
20th Jun 20164:40 pmRNSSecond Price Monitoring Extn
20th Jun 20164:35 pmRNSPrice Monitoring Extension
20th Jun 20167:00 amRNSTop-Line Results from Cat Allergy Phase III Study
1st Jun 20162:51 pmRNSHolding(s) in Company
31st May 20167:00 amRNSTotal Voting Rights
25th May 20167:00 amRNSGrass Registration Study Initiation
19th May 20163:33 pmRNSGrant of awards to Directors
19th May 20163:30 pmRNSAppointment of Broker
18th May 20165:28 pmRNSResult of AGM
11th May 20162:51 pmRNSHolding(s) in Company
29th Apr 20167:00 amRNSTotal Voting Rights
27th Apr 20165:02 pmRNSHolding(s) in Company
21st Apr 20164:39 pmRNSHolding(s) in Company
31st Mar 20167:00 amRNSTotal Voting Rights
22nd Mar 201611:47 amRNSPosting of Annual Report and Notice of AGM
11th Mar 20167:00 amRNSFull Year Results 2015
7th Mar 20163:21 pmRNSNotice of Results
29th Feb 20167:00 amRNSTotal Voting Rights
25th Feb 20165:03 pmRNSHolding(s) in Company
1st Feb 20167:00 amRNSTotal Voting Rights
15th Jan 20164:13 pmRNSDirector Declaration
8th Jan 20167:00 amRNSTR-1: Notification of Major Interest in Shares
31st Dec 20157:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.